Shahbal B. Kangarloo

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

Michelle Geddes, Shahbal B. Kangarloo, Naveed Farrukh et al. · Biology of Blood and Marrow Transplantation · 2008 · 148 citations · Full text

Medicine, Hematology, Pharmacology +17

Establishing a Target Exposure for Once-Daily Intravenous Busulfan Given with Fludarabine and Thymoglobulin before Allogeneic Transplantation

James A. Russell, Shahbal B. Kangarloo, Tyler Williamson et al. · Biology of Blood and Marrow Transplantation · 2013 · 39 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate Dosing

Shahbal B. Kangarloo, Naveed Farrukh, Ella S.M. Ng et al. · Biology of Blood and Marrow Transplantation · 2011 · 38 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels

Kareem Jamani, Rosy Dabas, Shahbal B. Kangarloo et al. · Biology of Blood and Marrow Transplantation · 2018 · 26 citations · Full text

Life Sciences, Hematology, Immunology +11

Predictive Performance of a Physiologically Based Pharmacokinetic Model of Busulfan in Children

C Diestelhorst, Joachim Boos, Jeannine S. McCune et al. · Pediatric Hematology and Oncology · 2014 · 22 citations

Pharmacy, Pharmacokinetics, Pharmacology +17